Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.47435 | 19 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.44749 | 19 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.44911 | 19 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.40382 | 19 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.38792 | 18 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.52661 | 19 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.44784 | 17 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.42501 | 18 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.41591 | 18 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.43824 | 19 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.43005 | 18 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.42847 | 19 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.43963 | 18 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.43455 | 18 |